RegeneRx Biopharmaceuticals Inc (RGRX)

[georgie18]

RGRX...16...Bullish Harami Cross Reversal Pattern formed to the Upside as the Bollies start to Squeeze...

RGRX...Looking for RGRX to Break the .16/.20 Consolidation Channel to the Upside and make a run at the previous high of .82 should they have positive news from the FDA meeting...imo...we shall see...

Chart... https://schrts.co/cbFeWPua ...

Will be adding more for the February FDA meeting...

ROCKVILLE, Md., Dec. 17, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the U.S. FDA has accepted its request for a pre-BLA meeting pursuant to RGN-259, its novel product candidate for dry eye syndrome. The meeting is scheduled for February 28, 2022. A BLA (Biologics License Application) is FDA's standard "full approval" mechanism for biological products, including therapeutics and vaccines.